IT8167863A0 - Zata a base di beta lattami protetcomposizione antibatterica liofilizta contro la formazione di colore e procedimento per la sua preparazione - Google Patents

Zata a base di beta lattami protetcomposizione antibatterica liofilizta contro la formazione di colore e procedimento per la sua preparazione

Info

Publication number
IT8167863A0
IT8167863A0 IT8167863A IT6786381A IT8167863A0 IT 8167863 A0 IT8167863 A0 IT 8167863A0 IT 8167863 A IT8167863 A IT 8167863A IT 6786381 A IT6786381 A IT 6786381A IT 8167863 A0 IT8167863 A0 IT 8167863A0
Authority
IT
Italy
Prior art keywords
zata
freeze
procedure
preparation
antibacterial composition
Prior art date
Application number
IT8167863A
Other languages
English (en)
Other versions
IT1144812B (it
Inventor
Eizo Hirai
Kazuhiro Shima
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of IT8167863A0 publication Critical patent/IT8167863A0/it
Application granted granted Critical
Publication of IT1144812B publication Critical patent/IT1144812B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
IT67863/81A 1980-06-23 1981-06-22 Composizione antibatterica liofilizzata a base di beta lattami protetta contro la formazione di colore e procedimento per la sua preparazione IT1144812B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8578980A JPS5711909A (en) 1980-06-23 1980-06-23 Stable freeze-dried preparation of beta-lactam

Publications (2)

Publication Number Publication Date
IT8167863A0 true IT8167863A0 (it) 1981-06-22
IT1144812B IT1144812B (it) 1986-10-29

Family

ID=13868648

Family Applications (1)

Application Number Title Priority Date Filing Date
IT67863/81A IT1144812B (it) 1980-06-23 1981-06-22 Composizione antibatterica liofilizzata a base di beta lattami protetta contro la formazione di colore e procedimento per la sua preparazione

Country Status (31)

Country Link
US (1) US4418058A (it)
JP (1) JPS5711909A (it)
KR (1) KR840000693B1 (it)
AR (1) AR230007A1 (it)
AT (1) AT380790B (it)
AU (1) AU541627B2 (it)
BE (1) BE889351A (it)
BG (1) BG37991A3 (it)
CA (1) CA1164801A (it)
CH (1) CH648210A5 (it)
CS (1) CS221835B2 (it)
DD (1) DD159879A5 (it)
DE (1) DE3124592A1 (it)
DK (1) DK158443C (it)
ES (1) ES503283A0 (it)
FI (1) FI75490C (it)
FR (1) FR2484835A1 (it)
GB (1) GB2078737B (it)
GR (1) GR75646B (it)
HU (1) HU183494B (it)
IE (1) IE51331B1 (it)
IL (1) IL63136A (it)
IT (1) IT1144812B (it)
NL (1) NL191777C (it)
NO (1) NO156036C (it)
NZ (1) NZ197414A (it)
PT (1) PT73239B (it)
RO (1) RO82720B (it)
SE (1) SE460702B (it)
YU (1) YU44416B (it)
ZA (1) ZA814203B (it)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597193A (ja) * 1982-07-02 1984-01-14 Shionogi & Co Ltd マロニルメチル基の異性化方法
JPS6045514A (ja) * 1983-08-22 1985-03-12 Shionogi & Co Ltd 安定な抗菌性凍結乾燥製剤
US4797388A (en) * 1984-05-21 1989-01-10 Cetus Corporation Pharmaceutical compositions with galactitol as carrier
US4891391A (en) * 1985-01-03 1990-01-02 Morton Thiokol, Inc. Compositions containing antimicrobial agents in combination with stabilizers
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones
DE3801179A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierung von cephalosporinderivaten durch trocknung mit einem stabilisator sowie stabile zubereitungsformen mit cephalosporinderivaten
BR0112417A (pt) * 2000-07-13 2003-07-01 Daiichi Seiyaku Co Composições farmacêuticas contendo composto dds
US7378408B2 (en) * 2001-11-30 2008-05-27 Pfizer Inc. Methods of treatment and formulations of cephalosporin
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
MX2020004205A (es) 2013-03-15 2021-11-16 Merck Sharp & Dohme Llc Composiciones antibioticas de ceftolozano.
US20140275000A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS532931B2 (it) * 1973-12-05 1978-02-01
US3928592A (en) * 1974-02-22 1975-12-23 Lilly Co Eli Antibiotic pharmaceutical compositions
US3993753A (en) * 1974-08-26 1976-11-23 American Home Products Corporation Anhydrous ampicillin stabilization and resultant compositions
GB1463563A (en) * 1974-10-10 1977-02-02 Beecham Group Ltd Pharmaceutical compositions
JPS5151511A (en) * 1974-10-25 1976-05-07 Tooru Tatsuhara Aminosanseizai no anteikaho
US4180571A (en) * 1976-03-25 1979-12-25 Shionogi & Co., Ltd. Arylmalonamido-1-oxadethiacephalosporins
JPS532931A (en) * 1976-06-30 1978-01-12 Saraya Kk Toilet bowl cleaning method
FR2374031A1 (fr) * 1976-12-17 1978-07-13 Scherico Ltd Nouvelles formulations d'antibiotiques b-lactame, leur procede de preparation, melange antibiotique injectable ainsi que son procede de preparation
JPS53104722A (en) * 1977-02-19 1978-09-12 Tsumura Juntendo Kk Production of powder for making herb medicine liquid agent
CA1127450A (en) * 1978-08-26 1982-07-13 Gordon L. Mcglennon Load multiplying mechanisms
US4259485A (en) * 1979-04-24 1981-03-31 Eli Lilly And Company Crystallization process

Also Published As

Publication number Publication date
RO82720A (ro) 1984-05-23
SE460702B (sv) 1989-11-13
DK274981A (da) 1981-12-24
NO156036C (no) 1987-07-15
BE889351A (fr) 1981-10-16
ES8203887A1 (es) 1982-04-01
YU44416B (en) 1990-08-31
SE8103904L (sv) 1981-12-24
YU157381A (en) 1984-10-31
KR830005848A (ko) 1983-09-14
JPS6364405B2 (it) 1988-12-12
GR75646B (it) 1984-08-02
CS221835B2 (en) 1983-04-29
DE3124592C2 (it) 1990-12-20
DD159879A5 (de) 1983-04-13
ES503283A0 (es) 1982-04-01
US4418058A (en) 1983-11-29
IL63136A (en) 1984-07-31
NL191777B (nl) 1996-04-01
FI75490B (fi) 1988-03-31
JPS5711909A (en) 1982-01-21
CH648210A5 (de) 1985-03-15
CA1164801A (en) 1984-04-03
PT73239A (en) 1981-07-01
AR230007A1 (es) 1984-02-29
GB2078737A (en) 1982-01-13
FR2484835B1 (it) 1983-07-01
DK158443B (da) 1990-05-21
FI811948L (fi) 1981-12-24
NZ197414A (en) 1984-10-19
NO812090L (no) 1981-12-28
FI75490C (fi) 1988-07-11
NL8102943A (nl) 1982-01-18
RO82720B (ro) 1984-07-30
IL63136A0 (en) 1981-09-13
IE51331B1 (en) 1986-12-10
AU541627B2 (en) 1985-01-17
AU7209781A (en) 1983-01-06
DE3124592A1 (de) 1982-02-11
KR840000693B1 (ko) 1984-05-21
IT1144812B (it) 1986-10-29
PT73239B (en) 1982-07-22
GB2078737B (en) 1984-03-14
DK158443C (da) 1990-10-08
ZA814203B (en) 1982-09-29
AT380790B (de) 1986-07-10
NO156036B (no) 1987-04-06
ATA278881A (de) 1985-12-15
NL191777C (nl) 1996-08-02
HU183494B (en) 1984-05-28
IE811347L (en) 1981-12-23
BG37991A3 (en) 1985-09-16
FR2484835A1 (fr) 1981-12-24

Similar Documents

Publication Publication Date Title
LV5376A3 (lv) Smekejamais izstradajums
EP0230995A3 (en) Light-sensitive composition
EP0239082A3 (en) Light-sensitive composition
KR860004626A (ko) 색백화장료
GB8613688D0 (en) Pharmaceutical composition
GB8708659D0 (en) Pharmaceutical composition
EP0262788A3 (en) Light-sensitive composition
GB2195121B (en) Light-sensitive composition
IT8167863A0 (it) Zata a base di beta lattami protetcomposizione antibatterica liofilizta contro la formazione di colore e procedimento per la sua preparazione
IT1212411B (it) Antibiotico a/16686 e procedimento per la sua preparazione.
GB8701014D0 (en) Light-sensitive composition
IT1209615B (it) Composizione farmaceutica
GB8628373D0 (en) Pharmaceutical composition
GB8709166D0 (en) Pharmaceutical composition
AU4542885A (en) Holzspaltgerat fur eine motorkettensage
GB8614189D0 (en) Pharmaceutical composition
GB8523284D0 (en) Colour sensor
IT1119917B (it) Composto antibatterico e procedimento per la sua preparazione
GB8621008D0 (en) Pharmaceutical composition
FR2573654B1 (fr) Preparations antibacteriennes lyophilisees
FR2572609B1 (fr) Camera de thermographie
GB8706824D0 (en) Pharmaceutical composition
BR6600366U (pt) Lapis-estojo de cor
KR860004624A (ko) 색백화장료
GB8402574D0 (en) Pharmaceutical formulation

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19950630